Lyell Wealth Management, LP Bristol Myers Squibb CO Transaction History

Lyell Wealth Management, LP

$1.1 Billion
Q4 2024

A detailed history of Lyell Wealth Management, LP transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Lyell Wealth Management, LP holds 5,645 shares of BMY stock, worth $326,732. This represents 0.03% of its overall portfolio holdings.

Number of Shares

5,645

Previous 5,645 -0.0%

Holding current value

$326,732

Previous $292,000 9.25%

% of portfolio

0.03%

Previous 0.03%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	SELL	$39.66 - $51.75 $4,957 - $6,468	-125 Reduced 2.17%	5,645 $292,000
Q2 2024 Aug 08, 2024	SELL	$40.25 - $52.99 $26,082 - $34,337	-648 Reduced 10.1%	5,770 $239,000
Q1 2024 May 03, 2024	SELL	$47.98 - $54.4 $53,017 - $60,112	-1,105 Reduced 14.69%	6,418 $348,000
Q4 2023 Feb 02, 2024	SELL	$48.48 - $57.85 $24,724 - $29,503	-510 Reduced 6.35%	7,523 $386,000
Q3 2023 Oct 31, 2023	SELL	$57.89 - $64.73 $182,353 - $203,899	-3,150 Reduced 28.17%	8,033 $466,000
Q2 2023 Aug 04, 2023	SELL	$63.71 - $70.74 $35,104 - $38,977	-551 Reduced 4.7%	11,183 $715,000
Q1 2023 May 03, 2023	SELL	$65.71 - $74.53 $49,413 - $56,046	-752 Reduced 6.02%	11,734 $813,000
Q4 2022 Jan 24, 2023	SELL	$68.48 - $81.09 $66,768 - $79,062	-975 Reduced 7.24%	12,486 $0
Q3 2022 Oct 24, 2022	BUY	$0.13 - $76.84 $110 - $65,160	848 Added 6.72%	13,461 $957,000
Q2 2022 Jul 28, 2022	BUY	$72.62 - $79.98 $5,083 - $5,598	70 Added 0.56%	12,613 $978,000
Q1 2022 May 04, 2022	BUY	$61.48 - $73.72 $106,360 - $127,535	1,730 Added 16.0%	12,543 $923,000
Q4 2021 Feb 08, 2022	SELL	$53.63 - $62.52 $25,474 - $29,697	-475 Reduced 4.21%	10,813 $674,000
Q3 2021 Nov 10, 2021	SELL	$59.17 - $69.31 $91,713 - $107,430	-1,550 Reduced 12.07%	11,288 $673,000
Q2 2021 Aug 09, 2021	SELL	$61.91 - $67.42 $742 - $809	-12 Reduced 0.09%	12,838 $858,000
Q1 2021 May 07, 2021	BUY	$59.34 - $66.74 $228,874 - $257,416	3,857 Added 42.89%	12,850 $818,000
Q4 2020 Feb 04, 2021	BUY	$57.74 - $65.43 $327,674 - $371,315	5,675 Added 171.04%	8,993 $562,000
Q3 2020 Nov 04, 2020	BUY	$57.43 - $63.64 $190,552 - $211,157	3,318 New	3,318 $200,000
Q1 2020 May 11, 2020	SELL	$46.4 - $67.43 $144,953 - $210,651	-3,124 Closed	0 $0
Q4 2019 Feb 05, 2020	BUY	$49.21 - $64.19 $153,732 - $200,529	3,124 New	3,124 $201,000
Q1 2019 May 06, 2019	SELL	$45.12 - $53.8 $705,767 - $841,539	-15,642 Closed	0 $0
Q4 2018 Feb 11, 2019	SELL	$48.76 - $63.23 $42,421 - $55,010	-870 Reduced 5.27%	15,642 $813,000
Q3 2018 Oct 30, 2018	SELL	$55.19 - $62.25 $253,874 - $286,350	-4,600 Reduced 21.79%	16,512 $1.03 Million
Q2 2018 Jul 30, 2018	SELL	$50.53 - $62.98 $647,137 - $806,584	-12,807 Reduced 37.76%	21,112 $1.17 Million
Q1 2018 May 07, 2018	SELL	$59.92 - $68.98 $59,920 - $68,980	-1,000 Reduced 2.86%	33,919 $2.15 Million
Q4 2017 Jan 30, 2018	SELL	$59.94 - $65.35 $303,356 - $330,736	-5,061 Reduced 12.66%	34,919 $2.14 Million
Q3 2017 Oct 26, 2017	BUY	$55.23 - $63.74 $2.21 Million - $2.55 Million	39,980	39,980 $2.55 Million

Others Institutions Holding BMY

# of Institutions

2,752

Shares Held

1.57B

Call Options Held

28M

Put Options Held

28.7M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lyell Wealth Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Lyell Wealth Management, LP with notifications on news.

Account

Lyell Wealth Management, LP Bristol Myers Squibb CO Transaction History